Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FB2MZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,260
Award facts
- Contract value 100% obligated
- $21,260.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,260.12 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on January 15, 2026, with completion scheduled for January 16, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is executed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables comprehensive global pharmaceutical support to military healthcare programs, covering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The contract supports critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Gemtesa (mirabegron) is a medication used to treat overactive bladder symptoms, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across various therapeutic areas.
Quick answers
Who was awarded contract SPE2DR26FB2MZ?
SPE2DR26FB2MZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FB2MZ worth?
The government has obligated $21,260 on SPE2DR26FB2MZ.
Is contract SPE2DR26FB2MZ an order under another contract?
Yes. SPE2DR26FB2MZ is a delivery order under SPE2DR25D2102, an indefinite delivery contract.
Was contract SPE2DR26FB2MZ competed?
The extent of competition for SPE2DR26FB2MZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award